SoCalBio Forum to Explore Latest Medical Devices for Treating Obesity

L.A.-Area Companies Lead the Nation in Innovation; Forum Panelists Will Discuss Business and Regulatory Issues Behind Device-Based Obesity Care

LOS ANGELES & IRVINE, Calif.--()--The Southern California Biomedical Council (SoCalBio) will host a discussion on the latest medical devices for treating obesity during its networking forum on Thursday, March 25th (7:00 - 9:30 am) at the UC Irvine University Club.

The forum will include a keynote by Bill Murray, president and CEO of Reshape Medical - the San Clemente firm behind a new device-based treatment for morbid obesity. Currently undergoing clinical trials, the treatment involves inserting a balloon into the stomach via a procedure that is far less-invasive than lap-band or gastric bypass surgery.

Following Murray's keynote, a panel of local experts will discuss key issues - from regulation and business development to reimbursement and healthcare reform - impacting the device-based obesity care industry.

Panelists include:

  • Fred Cahn, PhD, CEO of Biomedical Strategies LLC (La Jolla)
  • Neal Kaufman, MD, MPH, Founder and CEO of DPS Health (Los Angeles)
  • Tom Kinder, CEO of Bariatric Advantage, Inc. (Irvine)
  • Roger Zickfeld, Managing Director of Zickfeld Advisors (Los Angeles)
  • Monica Welling, Partner at Atheln, Inc. (Los Angeles)

"According to the CDC, almost one out of every three adults in the U.S. is obese, and of those about 10 million are morbidly obese and may be helped by device-based treatments developed here in Southern California," said Ahmed Enany, president and CEO of SoCalBio. "Attendees at the forum on March 25th will get up to speed on all the latest innovations."

As the medical need for obesity management has skyrocketed, innovations developed in Southern California continue to transform the standard of care. Examples include the LapBand from BioEnterics (acquired by Inamed Corp and now part of Allergan Medical) and a new endoscopic gastrointestinal bypass sleeve device from ValenTx.

More information about the March 25th Forum is available on the SoCalBio Web site at

SoCalBio Forum sponsors include Berliner & Associates, Bolton & Company, Ernst & Young, Image 2000, Perkins Coie, VWR and Wells Fargo Insurance Services.

About the Southern California Biomedical Council (SoCalBio)

The Southern California Biomedical Council is a nonprofit, member-supported trade association that fosters life-science R&D, manufacturing, job creation and overall economic growth in the six counties (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino) that comprise the Greater Los Angeles region.

The Council’s programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policy makers and the public at-large about the benefits of the region’s life-science industry. The annual SoCalBio Investor & Partnership Conference has grown to become the region's largest showcase for emerging life-science companies and technologies.

SoCalBio is open to membership by local firms and organizations engaged in life-science technology development and commercialization. More information is available at


ExcelPR Group
Erik Deutsch, 323-851-2300 x112


ExcelPR Group
Erik Deutsch, 323-851-2300 x112